Literature DB >> 16051811

Composition and assembly of STAT-targeting ubiquitin ligase complexes: paramyxovirus V protein carboxyl terminus is an oligomerization domain.

Christina M Ulane1, Alex Kentsis, Cristian D Cruz, Jean-Patrick Parisien, Kristi L Schneider, Curt M Horvath.   

Abstract

Transcription regulators STAT1 and STAT2 are key components of the interferon signaling system leading to innate antiviral immunity. The related STAT3 protein is a regulator of interleukin-6-type cytokine signals and can contribute to both cell growth and death important for cancer gene regulation and tumor survival. These three STAT proteins are targeted for proteasome-mediated degradation by RNA viruses in the Rubulavirus genus of the Paramyxoviridae. A single viral protein, the V protein, assembles STAT-specific ubiquitin ligase complexes from cellular components. Simian virus 5 (SV5) targets STAT1, human parainfluenza virus 2 targets STAT2, and mumps virus targets both STAT1 and STAT3. Analysis of the V-dependent degradation complex (VDC) composition and assembly revealed several features contributing to targeting specificity. SV5 and mumps V proteins require STAT2 to recruit the STAT1 target, yet mumps V protein binds STAT3 independent of STAT1 and STAT2. All Rubulavirus V proteins tested require cellular DDB1 to target STATs for degradation but differ in the use of Roc1, which is essential for mumps V STAT3 targeting. Protein interaction analysis reveals that paramyxovirus V proteins can homo- and heterooligomerize and that the conserved cysteine-rich zinc-binding C-terminal domain is necessary and sufficient for oligomerization. Purified SV5 V protein spontaneously assembles into spherical macromolecular particles, and similar particles constitute SV5 and mumps VDC preparations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16051811      PMCID: PMC1182666          DOI: 10.1128/JVI.79.16.10180-10189.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  67 in total

1.  Recovery of infectious human parainfluenza type 2 virus from cDNA clones and properties of the defective virus without V-specific cysteine-rich domain.

Authors:  M Kawano; M Kaito; Y Kozuka; H Komada; N Noda; K Nanba; M Tsurudome; M Ito; M Nishio; Y Ito
Journal:  Virology       Date:  2001-05-25       Impact factor: 3.616

2.  Control of biochemical reactions through supramolecular RING domain self-assembly.

Authors:  Alex Kentsis; Ronald E Gordon; Katherine L B Borden
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-18       Impact factor: 11.205

3.  The ubiquitin ligase activity in the DDB2 and CSA complexes is differentially regulated by the COP9 signalosome in response to DNA damage.

Authors:  Regina Groisman; Jolanta Polanowska; Isao Kuraoka; Jun-ichi Sawada; Masafumi Saijo; Ronny Drapkin; Alexei F Kisselev; Kiyoji Tanaka; Yoshihiro Nakatani
Journal:  Cell       Date:  2003-05-02       Impact factor: 41.582

4.  STATs dimerize in the absence of phosphorylation.

Authors:  Jutta Braunstein; Siska Brutsaert; Rich Olson; Christian Schindler
Journal:  J Biol Chem       Date:  2003-06-28       Impact factor: 5.157

5.  The p127 subunit (DDB1) of the UV-DNA damage repair binding protein is essential for the targeted degradation of STAT1 by the V protein of the paramyxovirus simian virus 5.

Authors:  J Andrejeva; E Poole; D F Young; S Goodbourn; R E Randall
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

6.  The xeroderma pigmentosum group E gene product DDB2 is a specific target of cullin 4A in mammalian cells.

Authors:  A Nag; T Bondar; S Shiv; P Raychaudhuri
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

7.  SAG/ROC2/Rbx2/Hrt2, a component of SCF E3 ubiquitin ligase: genomic structure, a splicing variant, and two family pseudogenes.

Authors:  M Swaroop; M Gosink; Y Sun
Journal:  DNA Cell Biol       Date:  2001-07       Impact factor: 3.311

8.  STAT3 ubiquitylation and degradation by mumps virus suppress cytokine and oncogene signaling.

Authors:  Christina M Ulane; Jason J Rodriguez; Jean-Patrick Parisien; Curt M Horvath
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

9.  Paramyxoviruses SV5 and HPIV2 assemble STAT protein ubiquitin ligase complexes from cellular components.

Authors:  Christina M Ulane; Curt M Horvath
Journal:  Virology       Date:  2002-12-20       Impact factor: 3.616

10.  STAT protein interference and suppression of cytokine signal transduction by measles virus V protein.

Authors:  Heidi Palosaari; Jean-Patrick Parisien; Jason J Rodriguez; Christina M Ulane; Curt M Horvath
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

View more
  60 in total

1.  The measles virus V protein binds to p65 (RelA) to suppress NF-kappaB activity.

Authors:  Kerstin M Schuhmann; Christian K Pfaller; Karl-Klaus Conzelmann
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

2.  Dissociation of paramyxovirus interferon evasion activities: universal and virus-specific requirements for conserved V protein amino acids in MDA5 interference.

Authors:  Aparna Ramachandran; Curt M Horvath
Journal:  J Virol       Date:  2010-08-18       Impact factor: 5.103

3.  Deregulation of DNA damage signal transduction by herpesvirus latency-associated M2.

Authors:  Xiaozhen Liang; Mary T Pickering; Nam-Hyuk Cho; Heesoon Chang; Michael R Volkert; Timothy F Kowalik; Jae U Jung
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

4.  A shared interface mediates paramyxovirus interference with antiviral RNA helicases MDA5 and LGP2.

Authors:  Jean-Patrick Parisien; Darja Bamming; Akihiko Komuro; Aparna Ramachandran; Jason J Rodriguez; Glen Barber; Robert D Wojahn; Curt M Horvath
Journal:  J Virol       Date:  2009-04-29       Impact factor: 5.103

Review 5.  Paramyxovirus disruption of interferon signal transduction: STATus report.

Authors:  Aparna Ramachandran; Curt M Horvath
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

6.  Inflammasome Antagonism by Human Parainfluenza Virus Type 3 C Protein.

Authors:  Niraj K Shil; Swechha M Pokharel; Amiya K Banerjee; Michael Hoffman; Santanu Bose
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

Review 7.  Paramyxovirus evasion of innate immunity: Diverse strategies for common targets.

Authors:  Michelle D Audsley; Gregory W Moseley
Journal:  World J Virol       Date:  2013-05-12

8.  Growth restriction of an experimental live attenuated human parainfluenza virus type 2 vaccine in human ciliated airway epithelium in vitro parallels attenuation in African green monkeys.

Authors:  Anne Schaap-Nutt; Margaret A Scull; Alexander C Schmidt; Brian R Murphy; Raymond J Pickles
Journal:  Vaccine       Date:  2010-02-20       Impact factor: 3.641

9.  Interaction of mumps virus V protein variants with STAT1-STAT2 heterodimer: experimental and theoretical studies.

Authors:  Nora H Rosas-Murrieta; Irma Herrera-Camacho; Helen Palma-Ocampo; Gerardo Santos-López; Julio Reyes-Leyva
Journal:  Virol J       Date:  2010-10-11       Impact factor: 4.099

10.  Human parainfluenza virus type 2 V protein inhibits interferon production and signaling and is required for replication in non-human primates.

Authors:  Anne Schaap-Nutt; Christopher D'Angelo; Margaret A Scull; Emerito Amaro-Carambot; Machiko Nishio; Raymond J Pickles; Peter L Collins; Brian R Murphy; Alexander C Schmidt
Journal:  Virology       Date:  2009-12-07       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.